Immune responses to adenovirus vectors in the nervous system.

Immune responses to adenovirus vectors in the nervous system.

Non-replicating adenovirus vectors are being developed as vehicles for gene transfer into cells of the nervous system. An important requirement for successful gene transfer is the absence of deleterious cytotoxic or inflammatory side effects of the delivery system. Despite offering relatively stable...

Descripció completa

Dades bibliogràfiques
Autors principals:	Wood, M, Charlton, H, Wood, K, Kajiwara, K, Byrnes, A
Format:	Journal article
Idioma:	English
Publicat:	1996

Ítems similars

Humoral immune responses to adenovirus vectors in the brain.
per: Kajiwara, K, et al.
Publicat: (2000)

Immune responses to adenoviral vectors during gene transfer in the brain.
per: Kajiwara, K, et al.
Publicat: (1997)

Role of T cells in inflammation caused by adenovirus vectors in the brain.
per: Byrnes, A, et al.
Publicat: (1996)

Variation in the immune response to adenoviral vectors in the brain: influence of mouse strain, environmental conditions and priming.
per: Ohmoto, Y, et al.
Publicat: (1999)

Adenovirus gene transfer causes inflammation in the brain.
per: Byrnes, A, et al.
Publicat: (1995)

Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination.
per: Byrnes, A, et al.
Publicat: (1996)

Cytokine Responses to Adenovirus and Adenovirus Vectors
per: Svetlana Atasheva, et al.
Publicat: (2022-04-01)

Specific patterns of defective HSV-1 gene transfer in the adult central nervous system: implications for gene targeting.
per: Wood, M, et al.
Publicat: (1994)

Th1 cytokines are upregulated by adenoviral vectors in the brains of primed mice.
per: Lee, M, et al.
Publicat: (2008)

Adenovirus Vector-Derived VA-RNA-Mediated Innate Immune Responses
per: Hiroyuki Mizuguchi, et al.
Publicat: (2011-07-01)

Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum.
per: Andrew W Harmon, et al.
Publicat: (2018-01-01)

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
per: Catherine Collignon, et al.
Publicat: (2020-11-01)

The immune response to intracerebral neural grafts.
per: Sloan, D, et al.
Publicat: (1991)

Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule
per: Rollier, CS, et al.
Publicat: (2020)

Rapid-response manufacturing of adenovirus-vectored vaccines
per: Joe, CCD, et al.
Publicat: (2023)

The effect of polymer coating and different adenovirus serotypes on the innate immune responses to intraperitoneal adenovirus
per: Thoma, C, et al.
Publicat: (2008)

Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine.
per: Aseem Pandey, et al.
Publicat: (2012-01-01)

Novel adenovirus vaccine vectors
per: Dicks, M
Publicat: (2013)

Evaluation of anti-vector immune responses to adenovirus-mediated lung gene therapy and modulation by αCD20
per: Robert D.E. Clark, et al.
Publicat: (2024-09-01)

An Oil-Based Adjuvant Improves Immune Responses Induced by Canine Adenovirus-Vectored Vaccine in Mice
per: Manon Broutin, et al.
Publicat: (2023-07-01)

Simian adenoviruses as vaccine vectors
per: Morris, S, et al.
Publicat: (2016)

Simian adenoviruses as vaccine vectors
per: Morris, S, et al.
Publicat: (2016)

Immune responses to novel adenovirus type 26 and modified vaccinia virus Ankara-vectored ebola vaccines at 1 year
per: Winslow, R, et al.
Publicat: (2017)

Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea.
per: Oral, H, et al.
Publicat: (1997)

Uncovering the mechanisms of adenovirus vector immunogenicity
per: Dicks, M, et al.
Publicat: (2013)

Immune recognition of Gene Transfer Vectors: Focus on Adenovirus as a paradigm
per: Andrea eAmalfitano, et al.
Publicat: (2011-09-01)

Potential and limitations of a gamma 34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS.
per: McMenamin, M, et al.
Publicat: (1998)

Genetic Adjuvants in Replicating Single-Cycle Adenovirus Vectors Amplify Systemic and Mucosal Immune Responses against HIV-1 Envelope
per: William E. Matchett, et al.
Publicat: (2020-02-01)

Adenovirus-vectored novel African Swine Fever Virus antigens elicit robust immune responses in swine.
per: Shehnaz Lokhandwala, et al.
Publicat: (2017-01-01)

Transient foamy virus vector production by adenovirus vectors.
per: Russell, R, et al.
Publicat: (2004)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity.
per: Reyes-Sandoval, A, et al.
Publicat: (2012)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity
per: Reyes-Sandoval, A, et al.
Publicat: (2012)

Increasing the Efficacy of Oncolytic Adenovirus Vectors
per: William S. M. Wold, et al.
Publicat: (2010-08-01)

Binding of adenovirus species C hexon to prothrombin and the influence of hexon on vector properties in vitro and in vivo.
per: Jie Tian, et al.
Publicat: (2022-09-01)

Adenovirus vector system: construction, history and therapeutic applications
per: Anum Syyam, et al.
Publicat: (2022-12-01)

Fiber-Modified Adenovirus for Central Nervous System Parkinson’s Disease Gene Therapy
per: Travis B. Lewis, et al.
Publicat: (2014-08-01)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
per: Dicks, M, et al.
Publicat: (2012)

Adenovirus-vectored immunocontraception in rat model
per: Lo, Sewn Cen
Publicat: (2012)

Adenovirus as a Vector and Oncolytic Virus
per: Wataru Matsunaga, et al.
Publicat: (2023-06-01)

Immune responses to non-tumor antigens in the central nervous system
per: Amanda K. Huber, et al.
Publicat: (2014-11-01)